Single-use Bioprocessing Market Expected to Reach $38.8 Billion by 2030

According to a new report published by Allied Market Research, titled, “Single-use Bioprocessing Market," The single-use bioprocessing market share was valued at $7.0 billion in 2020, and is estimated to reach $38.8 billion by 2030, growing at a CAGR of 18.4% from 2021 to 2030.

Rise in the adoption of single-use technologies, lower risk of product cross-contamination, and less floor space requirements drive the single-use bioprocessing market. In addition, single-use bioprocessing technologies are highly efficient and cost-effective, which attract pharmaceutical manufacturers to adopt disposable bioprocessing products, thus propelling the demand for single-use bioprocessing technologies. However, extractability and leachability issues, along with stringent regulations restrain the market growth. Moreover, untapped markets such as China and India offer profitable opportunities to expand this market.

The ingle-use bioprocessing market market growth is expected to witness significant growth during the forecast period due to factors such as advantages offered by Single-Use Technology (SUT), such as significant reduction in capital cost and facility construction time. Along with this, several CMOs and biomanufacturers have shifted their business focus to the production of therapeutics against SARS-CoV-2 infection using disposable technologies. In September 2020, Serum Institute selected ABEC’s Custom Single Run (CSR) technology to accelerate large-scale, single-use manufacturing of nearly 1.0 billion doses of Novavax vaccine, which is designed against COVID-19.

The Single-use bioprocessing market trends in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the bio manufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb).

By application, the market is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.

By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of method, the filtration segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.

On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.

Region wise, North America dominated the single-use bioprocessing industry in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. In addition, rise in the adoption of single-use bioprocessing technologies for various biopharmaceutical applications has propelled the growth of the market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others. In addition, Asia-Pacific witnessed strong growth in both the pharma and laboratory equipment market, which is anticipated to offer lucrative opportunities for single-use bioprocessing products in future.

KEY FINDINGS OF STUDY

• On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market size and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers are used in various bioprocessing processes.
• On the basis of method, the filtration segment dominated the global single-use bioprocessing industry in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.
• On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is projected to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.
• On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market in 2020 and is expected to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.
• Region wise, North America dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies